How fast is Wegovy weight loss, and what shapes the pace?

Step 1, the first four weeks: appetite shifts before the scales do

There is a common assumption that weight loss on Wegovy should be dramatic from the very first injection. In practice, the starting dose of 0.25mg is a tolerability measure, its job is to let your body adjust to the medicine, not to deliver maximum effect. Appetite suppression begins almost immediately for many people: meals feel filling sooner, cravings quieten a little, and the urge to snack between meals often reduces. The weight-loss signal in week one or two may be small, but that shift in appetite is doing real work.

By the end of the first month, many people have lost some weight, though the range is wide. Those who carry more weight to begin with tend to see larger absolute numbers early on, even if the percentage loss is similar. If the scales have barely moved in week three, that is not a signal that Wegovy is failing, the titration is still finding its footing. You can read more about what drives those early changes on our page on how fast Wegovy starts working.

Step 2, months two to four: dose increases and gathering momentum

The dose escalation continues roughly every four weeks: 0.25mg to 0.5mg, then 1.0mg, then 1.7mg, before reaching the 2.4mg maintenance dose at around week 16. Each step up tends to bring a renewed reduction in appetite. For most people, the rate of weight loss picks up noticeably as the dose climbs. This is the phase where the difference between Wegovy and willpower alone becomes clearer.

Side effects (nausea, some stomach discomfort, occasional constipation) are also most common during and after dose increases, and they generally settle within a week or two. Eating slowly, choosing lower-fat meals during the adjustment, and staying well hydrated all help. The NHS semaglutide patient guide outlines what to watch for and when to contact your prescriber. Weight loss during this phase is real and often visible; it is also still building toward the full dose's effect.

Step 3, months four to eighteen: sustained loss at maintenance dose

Once at 2.4mg, weight loss continues for most people, though the rate slows as the body adjusts. This plateau behaviour is normal and well-documented: the body defends against rapid ongoing loss. Progress measured across three or four months is more meaningful than week-to-week fluctuations, which can be influenced by fluid retention, menstrual cycle, and dietary variation.

The STEP 1 trial ran for 68 weeks (roughly 16 months). By that point, participants on 2.4mg semaglutide had lost an average of around 15% of body weight, equivalent to about 15 kg for someone starting at 100 kg. That is a substantial health outcome, not a cosmetic one. The full picture of what that looks like in practice is explored on our Wegovy weight loss overview. For context on how the weekly injection format compares with semaglutide's oral version, our Wegovy treatment page covers the current options available in the UK.

One factor people sometimes overlook: if fewer than 5% of body weight is lost after six months at the maintenance dose, NICE guidance recommends a clinical review to consider whether continuing is appropriate. That review is not a failure, it is the system working as intended. Our page on how long Wegovy takes to work goes deeper into what the 6-month checkpoint involves.

What makes the pace faster or slower for different people?

Several factors shape how quickly weight loss on semaglutide progresses. Starting BMI has an effect: people with higher initial weight tend to lose more in absolute terms, though percentage loss tends to be fairly consistent across groups in trials. Adherence to lifestyle changes (particularly a reduced-calorie diet and regular physical activity) amplifies the medicine's effect rather than replacing it. Wegovy is licensed for use alongside both, not as a standalone intervention.

Metabolic conditions such as type 2 diabetes can slow the rate of loss compared to people without diabetes; this was observed in STEP 2 (a separate trial in participants with type 2 diabetes), where average weight loss was around 10% rather than 15%. Your prescriber can discuss what a realistic expectation looks like given your individual health picture.

Genetics, gut hormone response, and how well side effects are tolerated during titration all play smaller but real roles. The people who tend to see the fastest results are those who reach and stay at the 2.4mg dose, follow the diet and activity recommendations, and give treatment the full 16-plus weeks to build. If you are thinking about starting or are already on treatment and want to understand your timeline better, our personalised weight loss timeline page walks through the individual factors in more detail. For questions about how the semaglutide mechanism works across different formulations, see our semaglutide speed of action page.

Wegovy is available as a private prescription through regulated UK pharmacies. Treatment pricing details and what is included are shown on our treatment options page. Our clinical team reviews every consultation personally, if you think Wegovy may be right for you, checking your eligibility is a straightforward starting point.